Surrozen, Inc. discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
| Market Cap | 27.009 Million | Shares Outstanding | 35.123 Million | Avg 30-day Volume | 216.838 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.38 |
| Price to Revenue | 0.0 | Debt to Equity | 0.0511 | EBITDA | -48.142 Million |
| Price to Book Value | 0.9115 | Operating Margin | 0.0 | Enterprise Value | -4.208 Million |
| Current Ratio | 9.559 | EPS Growth | 0 | Quick Ratio | 9.059 |
| 1 Yr BETA | 0.7213 | 52-week High/Low | 3.73 / 0.34 | Profit Margin | 0.0 |
| Operating Cash Flow Growth | -19.0443 | Altman Z-Score | -0.5357 | Free Cash Flow to Firm | 0 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
PARKER CRAIG C CHIEF EXECUTIVE OFFICER |
|
0 | 2023-03-01 | 3 |
|
WILLIAMS CHARLES O CHIEF FINANCIAL OFFICER |
|
0 | 2023-02-01 | 3 |
|
YEH WEN-CHEN CHIEF SCIENTIFIC OFFICER |
|
0 | 2023-02-01 | 3 |
|
VANHOVE GEERTRUI CHIEF MEDICAL OFFICER |
|
32,412 | 2022-12-15 | 2 |
|
0 | 2022-12-14 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
20,000 | 2022-06-07 | 1 | |
|
6,382,500 | 2021-08-11 | 1 | |
|
9,248,129 | 2021-08-11 | 0 | |
|
1,885,000 | 2021-08-11 | 0 | |
|
1,885,000 | 2021-08-11 | 0 | |
|
1,885,000 | 2021-08-11 | 0 | |
|
0 | 2020-11-18 | 1 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
HOUSE JOSHUA CORY VP BUSINESS DEVELOPMENT |
|
0 | 2020-11-18 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 13:03:42 -0500 | 2023-03-01 | A | 405,000 | a | 405,000 | direct | ||||||||||
| 2023-02-02 16:32:00 -0500 | 2023-02-01 | A | 125,000 | a | 125,000 | direct | ||||||||||
| 2023-02-02 16:28:46 -0500 | 2023-02-01 | A | 125,000 | a | 125,000 | direct |
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| SURROZEN INC SRZN | 2023-03-24 22:15:03 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 21:45:03 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 21:15:03 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 20:45:03 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 20:15:04 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 19:45:03 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 19:15:04 UTC | -17.8457 | 22.6657 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 18:45:04 UTC | -17.8721 | 22.6921 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 18:15:03 UTC | -17.8721 | 22.6921 | 1000 |
| SURROZEN INC SRZN | 2023-03-24 17:45:03 UTC | -17.8721 | 22.6921 | 10000 |
| SURROZEN INC SRZN | 2023-03-24 17:15:03 UTC | -17.8721 | 22.6921 | 15000 |
| SURROZEN INC SRZN | 2023-03-24 16:45:03 UTC | -17.7523 | 22.5723 | 15000 |
| SURROZEN INC SRZN | 2023-03-24 16:15:03 UTC | -17.7523 | 22.5723 | 6000 |
| SURROZEN INC SRZN | 2023-03-24 15:45:03 UTC | -17.7523 | 22.5723 | 7000 |
| SURROZEN INC SRZN | 2023-03-24 15:15:03 UTC | -17.7523 | 22.5723 | 8000 |
| SURROZEN INC SRZN | 2023-03-24 14:45:03 UTC | -18.0023 | 22.5723 | 8000 |
| SURROZEN INC SRZN | 2023-03-24 14:15:03 UTC | -18.0023 | 22.5723 | 8000 |
| SURROZEN INC SRZN | 2023-03-24 13:45:03 UTC | -18.0023 | 22.5723 | 8000 |
| SURROZEN INC SRZN | 2023-03-24 13:15:04 UTC | -18.0023 | 22.5723 | 8000 |
| SURROZEN INC SRZN | 2023-03-24 12:45:03 UTC | -18.0023 | 22.5723 | 8000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
